Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
AIDS Malignancy Consortium
St. Jude Children's Research Hospital
GlaxoSmithKline
Eli Lilly and Company
Shasqi, Inc.
Medical University of South Carolina
Intensity Therapeutics, Inc.
BeiGene
Adaptimmune
Adaptimmune
Adaptimmune
Novartis
National Cancer Institute (NCI)
Hutchmed
ImmunityBio, Inc.
Theseus Pharmaceuticals
University of Virginia
RefleXion Medical
Novartis
Hoffmann-La Roche
Eisai Inc.
Gradalis, Inc.
GlaxoSmithKline
Bristol-Myers Squibb
Amgen
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
GlaxoSmithKline
Ohio State University
Pfizer
Novartis
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Children's Hospital of Philadelphia
InSightec
InSightec
Celgene
BioMed Valley Discoveries, Inc
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Novartis
SCRI Development Innovations, LLC
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.